✦ LIBER ✦

The Role of Self-Efficacy in HIV Treatment Adherence: Validation of the HIV Treatment Adherence Self-Efficacy Scale (HIV-ASES)

✍ Scribed by Mallory O. Johnson; Torsten B. Neilands; Samantha E. Dilworth; Stephen F. Morin; Robert H. Remien; Margaret A. Chesney

Publisher: Springer
Year: 2007
Tongue: English
Weight: 201 KB
Volume: 30
Category: Article
ISSN: 0160-7715
DOI: 10.1007/s10865-007-9118-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Medication Adherence Mediates the Relati

Medication Adherence Mediates the Relationship between Adherence Self-efficacy and Biological Assessments of HIV Health among those with Alcohol Use Disorders

✍ Jeffrey T. Parsons; Elana Rosof; Brian Mustanski 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 205 KB

Revision and validation of the medicatio

Revision and validation of the medication adherence self-efficacy scale (MASES) in hypertensive African Americans

✍ Senaida Fernandez; William Chaplin; Antoinette M. Schoenthaler; Gbenga Ogedegbe 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 317 KB

Self-Perception of Body Fat Changes and

Self-Perception of Body Fat Changes and HAART Adherence in the Women’s Interagency HIV Study

✍ Michael Plankey; Peter Bacchetti; Chengshi Jin; Barbara Grimes; Charles Hyman; M 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 169 KB

Longitudinal Antiretroviral Adherence in

Longitudinal Antiretroviral Adherence in HIV+ Ugandan Parents and Their Children Initiating HAART in the MTCT-Plus Family Treatment Model: Role of Depression in Declining Adherence Over Time

✍ Jayne Byakika-Tusiime; Johanna Crane; Jessica H. Oyugi; Kathleen Ragland; Annet 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 223 KB

Discrimination as a key mediator of the

Discrimination as a key mediator of the relationship between posttraumatic stress and HIV treatment adherence among African American men

✍ Glenn J. Wagner; Laura M. Bogart; Frank H. Galvan; Denedria Banks; David J. Klei 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 226 KB

Efficacy and safety of tenofovir double-

Efficacy and safety of tenofovir double-dose in treatment-experienced HIV-infected patients: The tenoplus study

✍ Stephanie Dominguez; Jade Ghosn; Gilles Peytavin; Hassan Izzedine; Marc Wirden; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB

## Abstract Drug resistance is an increasing problem in the treatment of HIV infection. Tenofovir has been shown to inhibit HIV replication even with thymidine‐associated resistance mutations (TAMs) if they are limited to two or less. Double‐dose of tenofovir disoproxil fumarate (TDF) (600 mg QD) w